These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23810026)

  • 1. The Oxford Implementation Index: a new tool for incorporating implementation data into systematic reviews and meta-analyses.
    Montgomery P; Underhill K; Gardner F; Operario D; Mayo-Wilson E
    J Clin Epidemiol; 2013 Aug; 66(8):874-82. PubMed ID: 23810026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Randomized Controlled Trials Rehabilitation Checklist: Methodology of Development of a Reporting Guideline Specific to Rehabilitation.
    Negrini S; Armijo-Olivo S; Patrini M; Frontera WR; Heinemann AW; Machalicek W; Whyte J; Arienti C;
    Am J Phys Med Rehabil; 2020 Mar; 99(3):210-215. PubMed ID: 31851008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should we evaluate the risk of bias of physical therapy trials?: a psychometric and meta-epidemiological approach towards developing guidelines for the design, conduct, and reporting of RCTs in Physical Therapy (PT) area: a study protocol.
    Armijo-Olivo S; Fuentes J; Rogers T; Hartling L; Saltaji H; Cummings GG
    Syst Rev; 2013 Sep; 2():88. PubMed ID: 24070072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, inter-rater reliability and feasibility of a checklist to assess implementation (Ch-IMP) in systematic reviews: the case of provider-based prevention and treatment programs targeting children and youth.
    Cargo M; Stankov I; Thomas J; Saini M; Rogers P; Mayo-Wilson E; Hannes K
    BMC Med Res Methodol; 2015 Sep; 15():73. PubMed ID: 26346461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.
    Faillie JL; Ferrer P; Gouverneur A; Driot D; Berkemeyer S; Vidal X; Martínez-Zapata MJ; Huerta C; Castells X; Rottenkolber M; Schmiedl S; Sabaté M; Ballarín E; Ibáñez L
    J Clin Epidemiol; 2017 Jun; 86():168-175. PubMed ID: 28487158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which resources should be used to identify RCT/CCTs for systematic reviews: a systematic review.
    Crumley ET; Wiebe N; Cramer K; Klassen TP; Hartling L
    BMC Med Res Methodol; 2005 Aug; 5():24. PubMed ID: 16092960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.
    Boutron I; Moher D; Tugwell P; Giraudeau B; Poiraudeau S; Nizard R; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1233-40. PubMed ID: 16291467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.
    Zeng X; Zhang Y; Kwong JS; Zhang C; Li S; Sun F; Niu Y; Du L
    J Evid Based Med; 2015 Feb; 8(1):2-10. PubMed ID: 25594108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.
    Webster L; Groskreutz D; Grinbergs-Saull A; Howard R; O'Brien JT; Mountain G; Banerjee S; Woods B; Perneczky R; Lafortune L; Roberts C; McCleery J; Pickett J; Bunn F; Challis D; Charlesworth G; Featherstone K; Fox C; Goodman C; Jones R; Lamb S; Moniz-Cook E; Schneider J; Shepperd S; Surr C; Thompson-Coon J; Ballard C; Brayne C; Burke O; Burns A; Clare L; Garrard P; Kehoe P; Passmore P; Holmes C; Maidment I; Murtagh F; Robinson L; Livingston G
    Health Technol Assess; 2017 May; 21(26):1-192. PubMed ID: 28625273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological developments in searching for studies for systematic reviews: past, present and future?
    Lefebvre C; Glanville J; Wieland LS; Coles B; Weightman AL
    Syst Rev; 2013 Sep; 2():78. PubMed ID: 24066664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
    Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
    BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study.
    Akl EA; Kahale LA; Agarwal A; Al-Matari N; Ebrahim S; Alexander PE; Briel M; Brignardello-Petersen R; Busse JW; Diab B; Iorio A; Kwong J; Li L; Lopes LC; Mustafa R; Neumann I; Tikkinen KA; Vandvik PO; Zhang Y; Alonso-Coello P; Guyatt G
    Syst Rev; 2014 Nov; 3():137. PubMed ID: 25423894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.